Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
3M | MMM | 28. mar 2025 | 144.84 | -2.43 |
4D Molecular Therapeutics | FDMT | 28. mar 2025 | 3.63 | +1.97 |
51Talk Online Education Group ADR | COE | 28. mar 2025 | 21.01 | +1.45 |
5E Advanced Materials | FEAM | 28. mar 2025 | 4.10 | +1.22 |
60 Degrees Pharmaceuticals | SXTP | 28. mar 2025 | 1.84 | +1.10 |
7-10 Yr Trsy Bear 3X Direxion | TYO | 28. mar 2025 | 13.68 | -2.22 |
7-10 Yr Trsy Bull 3X Direxion | TYD | 28. mar 2025 | 25.14 | +2.28 |
7-10 Yr Trsy Ishares | IEF | 28. mar 2025 | 95.09 | +0.81 |
89bio | ETNB | 28. mar 2025 | 8.08 | -9.82 |
8x8 | EGHT | 28. mar 2025 | 1.99 | -5.69 |
908 Devices | MASS | 28. mar 2025 | 4.04 | +0.75 |
9F ADR | JFU | 28. mar 2025 | 1.41 | -6.00 |
A-Mark Precious Metals | AMRK | 28. mar 2025 | 26.45 | -6.90 |
a.k.a Brands | AKA | 28. mar 2025 | 14.29 | -0.97 |
A.O Smith | AOS | 28. mar 2025 | 65.61 | -1.93 |
A10 Networks | ATEN | 28. mar 2025 | 16.74 | -3.07 |
A2Z Cust2Mate Solutions | AZ | 28. mar 2025 | 7.31 | -1.48 |
AA Mission Acquisition | AAM | 28. mar 2025 | 10.28 | +0.10 |
AAA - A Rated Corporate Bond Ishares | QLTA | 28. mar 2025 | 47.44 | +0.47 |
Aadi Bioscience | AADI | 28. mar 2025 | 2.05 | 0.00 |
AAON | AAON | 28. mar 2025 | 78.08 | -2.69 |
AAR | AIR | 28. mar 2025 | 57.14 | -16.40 |
Aardvark Therapeutics | AARD | 28. mar 2025 | 7.74 | 0.00 |
Abacus Global Management | ABL | 28. mar 2025 | 7.62 | +6.57 |
Abbott Laboratories | ABT | 28. mar 2025 | 130.82 | -0.40 |
AbbVie | ABBV | 28. mar 2025 | 205.29 | +1.27 |
AbCellera Biologics | ABCL | 28. mar 2025 | 2.31 | -2.12 |
Abeona Therapeutics | ABEO | 28. mar 2025 | 4.97 | -1.39 |
Abercrombie & Fitch | ANF | 28. mar 2025 | 76.57 | -1.24 |
Aberdeen Asia-Pacificome Fund | FAX | 28. mar 2025 | 15.67 | +0.19 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.